Teva Pharmaceutical Industries (TEVA) Exchange Rate Effect: 2009-2025
Historic Exchange Rate Effect for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to -$9.0 million.
- Teva Pharmaceutical Industries' Exchange Rate Effect fell 109.00% to -$9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$90.0 million, marking a year-over-year decrease of 700.00%. This contributed to the annual value of -$174.0 million for FY2024, which is 480.00% down from last year.
- Teva Pharmaceutical Industries' Exchange Rate Effect amounted to -$9.0 million in Q3 2025, which was down 80.00% from -$5.0 million recorded in Q2 2025.
- Teva Pharmaceutical Industries' 5-year Exchange Rate Effect high stood at $146.0 million for Q4 2022, and its period low was -$123.0 million during Q2 2022.
- Moreover, its 3-year median value for Exchange Rate Effect was -$9.0 million (2025), whereas its average is -$15.7 million.
- Over the last 5 years, Teva Pharmaceutical Industries' Exchange Rate Effect had its largest YoY gain of 404.17% in 2022, and its largest YoY loss of 2,360.00% in 2022.
- Over the past 5 years, Teva Pharmaceutical Industries' Exchange Rate Effect (Quarterly) stood at -$48.0 million in 2021, then surged by 404.17% to $146.0 million in 2022, then crashed by 53.42% to $68.0 million in 2023, then crashed by 277.94% to -$121.0 million in 2024, then plummeted by 109.00% to -$9.0 million in 2025.
- Its Exchange Rate Effect was -$9.0 million in Q3 2025, compared to -$5.0 million in Q2 2025 and $45.0 million in Q1 2025.